Skip to content
healthcare.dev

Raxibacumab

NDC 71655-103, raxibacumab, injection, from Emergent BioDefense Operations Lansing.

Product NDC
71655-103
Status
Listed
Labeler
Emergent BioDefense Operations Lansing
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA125349
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71655-103 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RAXIBACUMAB50 mg/mL

Pharmacologic classes

Anthrax Protective Antigen-directed Antibody Interactions [MoA]; Anthrax Protective Antigen-directed Antibody [EPC]

Package NDCNDC-11Package
71655-103-01716550103011 VIAL, SINGLE-USE in 1 CARTON (71655-103-01) / 34 mL in 1 VIAL, SINGLE-USE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/f6927e91-bb46-47b3-ab66-f9d8a9d7b12a

Use it

Look up 71655-103 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71655-103 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71655-103. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.